Preliminary findings suggest that an 8-week course of adjunctive aripiprazole is well tolerated and may reduce comorbid obsessive-compulsive symptoms in patients with BP-I, with improvement persisting through a 4-week off-treatment follow-up.
Background: Evidence for repeated intranasal esketamine in obsessive–compulsive disorder (OCD) remains preliminary, particularly when OCD co-occurs with treatment-resistant depression (TRD). Methods: We report a 58-year-old woman treated with intranasal esketamine in routine clinical care for TRD; change in obsessive–c...
T. Barlattani, Giorgio Sernia, C. D'Amelio et al.· Psychiatry International· 0 citations
BACKGROUND
Borderline personality disorder (BLPD) is a complex and debilitating psychiatric condition with high prevalence and clinical and psychosocial burden. Psychotherapy is the recommended first-line treatment but, in real-world clinical practice, most individuals with BLPD are prescribed psychotropic medications,...
M. D'Incalci, C. M. Congedo, G. Agostoni et al.· Journal of Clinical Psychoph...· 0 citations
Anhedonia, a prominent symptom of major depressive disorder (MDD), severely impairs patients’ quality of life and is challenging to treat. Although esketamine has shown potential in treating anhedonia in adult treatment-resistant MDD, its effects on adolescents remain under-explored.
In this study, a prosp...
Qian-Qian Wu, Wei-Cheng Li, Zhan-Jie Luo et al.· BMC Psychiatry· 0 citations
Background Antipsychotic agents play a paradoxical role in obsessive–compulsive phenomena, augmenting selective serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder yet also inducing or worsening obsessive–compulsive symptoms, mainly in psychotic but also in mood disorders. How strongly in...
Muhanad Elnoor, Syed Ali Bokhari, S. Javaid· BJPsych Open· 0 citations
It is suggested that psilocybin therapy may be safe, tolerable, and preliminarily efficacious for treating depression in BD-II, but randomized controlled trials are needed to confirm efficacy and optimize protocols.
Amanda E. Downey, B. Szigeti, Ellen R. Bradley et al.· Journal of Clinical Psychiat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.